Replies to post #68572 on Biotech Values

[ghmm]

How about this for a list of criteria?
1. Unparterned
2. Not enough cash to bring the product to market
3. Lets say at least started Phase 3 trials
4. Its on a product basis so if company a has 2 unparterned Phase 3 products and not enough cash then an entry for each would be appropriate